Page 1 | Search Results | Anesthesiology | American Society of Anesthesiologists

1-20 of 47

Sort by

Sort Order Select

Articles

Encapsulation Dynamics of Neuromuscular Blocking Drugs by Sugammadex

Amir Hossein Irani, Ph.D., Logan Voss, Ph.D., Nicola Whittle, M.B.Ch.B., Jamie W. Sleigh, M.D.

Anesthesiology. February 2023: 138(2):152–163

https://doi.org/10.1097/ALN.0000000000004442

Published: February 2023

View article

Articles

Quantitative Neuromuscular Monitoring in Clinical Practice: A Professional Practice Change Initiative

Wade A. Weigel, M.D., Barbara L. Williams, Ph.D., Neil A. Hanson, M.D., C. Craig Blackmore, M.D., M.P.H., Randy L. Johnson, Cer.A.T., Gary M. Nissen, M.D., Andrew B. James, M.D., Wyndam M. Strodtbeck, M.D.

Anesthesiology. June 2022: 136(6):901–915

https://doi.org/10.1097/ALN.0000000000004174

Published: June 2022

View article

Articles

Preclinical Pharmacology in the Rhesus Monkey of CW 1759-50, a New Ultra-short Acting Nondepolarizing Neuromuscular Blocking Agent, Degraded and Antagonized by L-Cysteine

John J. Savarese, M.D., Hiroshi Sunaga, M.D., Jeff D. McGilvra, Ph.D., Matthew R. Belmont, M.D., Matthew T. Murrell, M.D., Ph.D., Erin Jeannotte, L.V.T., R.Lat.G., Farrell E. Cooke, B.S., William B. Wastila, Ph.D., Paul M. Heerdt, M.D., Ph.D.

Anesthesiology. November 2018: 129(5):970–988

https://doi.org/10.1097/ALN.0000000000002408

Published: November 2018

View article

Articles

Pharmacokinetic/Pharmacodynamic Model of CW002, an Investigational Intermediate Neuromuscular Blocking Agent, in Healthy Volunteers

Josh D. Kaullen, Pharm.D., Joel S. Owen, Ph.D., Kim L. R. Brouwer, Pharm.D., Ph.D., Paul M. Heerdt, M.D., Ph.D., Cynthia A. Lien, M.D., John J. Savarese, M.D., Virginia D. Schmith, Ph.D.

Anesthesiology. June 2018: 128(6):1107–1116

https://doi.org/10.1097/ALN.0000000000002157

Published: June 2018

View article

Articles

How to Catch Unicorns (and Other Fairytales)

Sorin J. Brull, M.D., F.C.A.R.C.S.I. (Hon), Mohamed Naguib, M.D., M.Sc., F.C.A.R.C.S.I.

Anesthesiology. January 2018: 128(1):1–3

https://doi.org/10.1097/ALN.0000000000001959

Published: January 2018

View article

Articles

Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities

Sorin J. Brull, M.D., F.C.A.R.C.S.I. (Hon), Aaron F. Kopman, M.D.

Anesthesiology. January 2017: 126(1):173–190

https://doi.org/10.1097/ALN.0000000000001409

Published: January 2017

View article

Articles

“To Reverse or Not To Reverse?”: The Answer Is Clear!

Glenn S. Murphy, M.D., Aaron F. Kopman, M.D.

Anesthesiology. October 2016: 125(4):611–614

https://doi.org/10.1097/ALN.0000000000001280

Published: October 2016

View article

Articles

Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia

Catherine M. Bulka, M.P.H., Maxim A. Terekhov, M.S., Barbara J. Martin, R.N., M.B.A., Roger R. Dmochowski, M.D., Rachel M. Hayes, B.S.N., Ph.D., Jesse M. Ehrenfeld, M.D., M.P.H.

Anesthesiology. October 2016: 125(4):647–655

https://doi.org/10.1097/ALN.0000000000001279

Published: October 2016

View article

Articles

Preclinical Pharmacology of CW002: A Nondepolarizing Neuromuscular Blocking Drug of Intermediate Duration, Degraded and Antagonized by l-cysteine—Additional Studies of Safety and Efficacy in the Anesthetized Rhesus Monkey and Cat

Hiroshi Sunaga, M.D., John J. Savarese, M.D., Jeff D. McGilvra, Ph.D., Paul M. Heerdt, M.D., Ph.D., Matthew R. Belmont, M.D., Scott G. Van Ornum, Ph.D., Matthew T. Murrell, M.D., Ph.D., Jaideep K. Malhotra, M.D., Peter M. Savard, M.D., Erin Jeannotte, L.V.T., R.Lat.G., Bryce J. Petty, B.A., Erica Allen, Ph.D., Gilbert W. Carnathan, Ph.D.

Anesthesiology. October 2016: 125(4):732–743

https://doi.org/10.1097/ALN.0000000000001254

Published: October 2016

View article

Articles

Neuromuscular Blocking Agent Cisatracurium Attenuates Lung Injury by Inhibition of Nicotinic Acetylcholine Receptor-α1

Vito Fanelli, M.D., Ph.D., Yasumasa Morita, M.D., Ph.D., Paola Cappello, Ph.D., Mirna Ghazarian, M.Sc., Bina Sugumar, B.Sc., Luisa Delsedime, M.D., Jane Batt, M.D., Ph.D., V. Marco Ranieri, M.D., Haibo Zhang, M.D., Ph.D., Arthur S. Slutsky, M.D.

Anesthesiology. January 2016: 124(1):132–140

https://doi.org/10.1097/ALN.0000000000000907

Published: January 2016

View article

Articles

Comparative Effectiveness of Calabadion and Sugammadex to Reverse Non-depolarizing Neuromuscular-blocking Agents

Friederike Haerter, Cand.Med., Jeroen Cedric Peter Simons, Cand.Med., Urs Foerster, M.D., Ingrid Moreno Duarte, M.D., Daniel Diaz-Gil, Cand.Med., Shweta Ganapati, B.S., Katharina Eikermann-Haerter, M.D., Cenk Ayata, M.D., Ben Zhang, Ph.D., Manfred Blobner, M.D., Lyle Isaacs, Ph.D., Matthias Eikermann, M.D., Ph.D.

Anesthesiology. December 2015: 123(6):1337–1349

https://doi.org/10.1097/ALN.0000000000000868

Published: December 2015

View article

Articles

Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications

Duncan J. McLean, M.B.Ch.B., Daniel Diaz-Gil, Cand.Med., Hassan N. Farhan, M.B.B.S., Karim S. Ladha, M.D., Tobias Kurth, M.D., Sc.D., Matthias Eikermann, M.D., Ph.D.

Anesthesiology. June 2015: 122(6):1201–1213

https://doi.org/10.1097/ALN.0000000000000674

Published: June 2015

View article

Articles

Calabadion: A New Agent to Reverse the Effects of Benzylisoquinoline and Steroidal Neuromuscular-blocking Agents

Ulrike Hoffmann, M.D., Martina Grosse-Sundrup, M.D., Katharina Eikermann-Haerter, M.D., Sebastina Zaremba, M.D., Cenk Ayata, M.D., Ben Zhang, B.S., Da Ma, Ph.D., Lyle Isaacs, Ph.D., Matthias Eikermann, M.D., Ph.D.

Anesthesiology. August 2013: 119(2):317–325

https://doi.org/10.1097/ALN.0b013e3182910213

Published: August 2013

View article

Articles

Anesthesia Literature Review

Anesthesiology. May 2013: 118(5):1209–1210

https://doi.org/10.1097/ALN.0b013e31828d342b

Published: May 2013

View article

Articles

Anesthesia Literature Review

Timothy J. Brennan, Ph.D., M.D.

Anesthesiology. February 2011: 114(2):432–437

https://doi.org/10.1097/ALN.0b013e318207fd7a

Published: February 2011

View article

Articles

Evaluation of a New Routine Diagnostic Test for Immunoglobulin E Sensitization to Neuromuscular Blocking Agents

Dominique Laroche, M.D., Ph.D., Sylvie Chollet-Martin, M.D., Ph.D., Pierre Léturgie, M.D., Laure Malzac, Pharm.G., M.Phil., Marie-Claude Vergnaud, M.D., Catherine Neukirch, M.D., Lennart Venemalm, Ph.D., Jean-Louis Guéant, M.D., Ph.D., Pascale Nicaise Roland, M.D., Ph.D.

Anesthesiology. January 2011: 114(1):91–97

https://doi.org/10.1097/ALN.0b013e31820164d2

Published: January 2011

View article

Articles

Cysteine Reversal of the Novel Neuromuscular Blocking Drug CW002 in Dogs: Pharmacodynamics, Acute Cardiovascular Effects, and Preliminary Toxicology

Hiroshi Sunaga, M.D., Jaideep K. Malhotra, M.D., Edward Yoon, B.S., John J. Savarese, M.D., Paul M. Heerdt, M.D., Ph.D.

Anesthesiology. April 2010: 112(4):900–909

https://doi.org/10.1097/ALN.0b013e3181d31f8c

Published: April 2010

View article

Articles

Pharmacodynamics and Cardiopulmonary Side Effects of CW002, a Cysteine-reversible Neuromuscular Blocking Drug in Dogs

Paul M. Heerdt, M.D., Ph.D., Jaideep K. Malhotra, M.D., Brian Y. Pan, B.S., Hiroshi Sunaga, M.D., John J. Savarese, M.D.

Anesthesiology. April 2010: 112(4):910–916

https://doi.org/10.1097/ALN.0b013e3181d31f71

Published: April 2010

View article

Articles

Neostigmine: How Much Is Necessary for Patients Who Receive a Nondepolarizing Neuromuscular Blocking Agent?

Cynthia A. Lien, M.D.

Anesthesiology. January 2010: 112(1):16–18

https://doi.org/10.1097/ALN.0b013e3181c5388f

Published: January 2010

View article

Articles

Pharmacological Characteristics of the Inhibition of Nondepolarizing Neuromuscular Blocking Agents at Human Adult Muscle Nicotinic Acetylcholine Receptor

Malin Jonsson Fagerlund, M.D., Ph.D., Michael Dabrowski, Ph.D., Lars I. Eriksson, M.D., Ph.D.

Anesthesiology. June 2009: 110(6):1244–1252

https://doi.org/10.1097/ALN.0b013e31819fade3

Published: June 2009

View article

NARROW

Encapsulation Dynamics of Neuromuscular Blocking Drugs by Sugammadex

Quantitative Neuromuscular Monitoring in Clinical Practice: A Professional Practice Change Initiative

Preclinical Pharmacology in the Rhesus Monkey of CW 1759-50, a New Ultra-short Acting Nondepolarizing Neuromuscular Blocking Agent, Degraded and Antagonized by L-Cysteine

Pharmacokinetic/Pharmacodynamic Model of CW002, an Investigational Intermediate Neuromuscular Blocking Agent, in Healthy Volunteers

How to Catch Unicorns (and Other Fairytales)

Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities

“To Reverse or Not To Reverse?”: The Answer Is Clear!

Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia

Preclinical Pharmacology of CW002: A Nondepolarizing Neuromuscular Blocking Drug of Intermediate Duration, Degraded and Antagonized by l-cysteine—Additional Studies of Safety and Efficacy in the Anesthetized Rhesus Monkey and Cat

Neuromuscular Blocking Agent Cisatracurium Attenuates Lung Injury by Inhibition of Nicotinic Acetylcholine Receptor-α1

Comparative Effectiveness of Calabadion and Sugammadex to Reverse Non-depolarizing Neuromuscular-blocking Agents

Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications

Calabadion: A New Agent to Reverse the Effects of Benzylisoquinoline and Steroidal Neuromuscular-blocking Agents

Anesthesia Literature Review

Anesthesia Literature Review

Evaluation of a New Routine Diagnostic Test for Immunoglobulin E Sensitization to Neuromuscular Blocking Agents

Cysteine Reversal of the Novel Neuromuscular Blocking Drug CW002 in Dogs: Pharmacodynamics, Acute Cardiovascular Effects, and Preliminary Toxicology

Pharmacodynamics and Cardiopulmonary Side Effects of CW002, a Cysteine-reversible Neuromuscular Blocking Drug in Dogs

Neostigmine: How Much Is Necessary for Patients Who Receive a Nondepolarizing Neuromuscular Blocking Agent?

Pharmacological Characteristics of the Inhibition of Nondepolarizing Neuromuscular Blocking Agents at Human Adult Muscle Nicotinic Acetylcholine Receptor

Email alerts

Email alerts

This Feature Is Available To Subscribers Only